India's first mRNA vaccine gets nod for human trials

The country's first indigenous mRNA vaccine candidate developed by Gennova, Pune has received approval from drug regulators to initiate Phase 1/2 human clinical trials, the Department of......

Chinese drugs pose threat to Indian pharma

Cheap bulk drug imports from China may soon post a threat to the Rs 20,000 crore (Rs 200 billion) domestic bulk drug industry. Indian companies are finding it impossible to arrest the trend as the......